1 Erratum to: Am J Cardiovasc Drugs (2015) 15:235–242 DOI 10.1007/s40256-015-0123-6

Author would like to correct Table 1 data under the column headings, ‘Major bleeding: NOAC’ and ‘Major bleeding: VKA’ in the published article.

Page 237, Table 1, Row 5 which previously read:

ROCKET-AF [47]

14,264

5.6/year

5.4/year

The corrected table should read:

Table 1 Rates of major bleeding for NOAC and standard of care (warfarin in SPAF trials and LMWH/warfarin in VTE trials) in phase-III trials and meta-analyses
Full size table